iPhone | iPad
Android
Huawei
The announcement coincides with a drop in the number of registered coronavirus cases
KT APPDOWNLOAD
Covid-19: Bahrain approves Sinopharm vaccine for children aged 3-11
Photo: FIle
Manama - Pfizer-BioNTech vaccine will soon be approved for children aged 5 to 11 age
Bahrain's National Medical Taskforce for Combatting the Coronavirus (Covid-19) announced that following approval by the Vaccination Committee, all children aged 3 to 11 will be eligible to receive two doses of the Sinopharm vaccine, starting Wednesday, October 27 2021.
The Taskforce noted that the decision was taken following a thorough review of all medical health and safety recommendations conducted by the Vaccination Committee, adding that the move aims to preserve public health.
Additionally, the Pfizer-BioNTech vaccine will soon be approved for children aged 5 to 11 age who will be eligible to receive two doses.
Full details will be announced on the Ministry of Health's website.
The Taskforce stressed that it is important that eligible children get vaccinated to protect themselves, their families, and public health.
To register children for the vaccination, people should visit the Ministry of Health's website at: healthalert.gov.bh or register through the BeAware application.
The Taskforce noted that registration requires the consent of a legal guardian.
The children must also have an adult accompanying them when receiving their vaccination.
More news from coronavirus
Over 178.6 million PCR tests have been conducted in the country so far
A total of at least eight cities and towns say their residents must not go beyond where they live
City health officials warn infections could hit 8,000 in the coming weeks
Foreigners who want to leave must test negative in five PCR tests over seven days
Over 178.6 million PCR tests have been conducted in the country so far
It will last for four weeks if 10 or more passengers test positive
Over 178.4 million PCR tests have been conducted in the country so far